(Q40394607)

20 September 2017

1 reference

title

Prostate cancer, screening, and prostate-specific antigen: promise or peril? (English)

1 reference

prostate cancer screening

20 September 2017

1 reference

J D Voss

1

1 reference

PubMed ID

7525903

20 September 2017

language of work or name

1 reference

1 August 1994

1 reference

Journal of General Internal Medicine

20 September 2017

1 reference

20 September 2017

9

1 reference

20 September 2017

8

1 reference

20 September 2017

468-474

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02599070

20 September 2017

0 references

cites work

Risk factors for prostate cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02599070

Prostate cancer: screening, diagnosis, and management

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02599070

Carcinoma of the prostate

21 January 2018

1 reference

12 December 2020

The national survey of prostate cancer in the United States by the American College of Surgeons

1 reference

12 December 2020

Deferred treatment for prostate cancer

1 reference

12 December 2020

The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey

1 reference

12 December 2020

Diagnostic Methods in the Detection of Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

1 reference

12 December 2020

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

12 December 2020

Expectant management of localized prostatic cancer

1 reference

12 December 2020

Early detection of prostate cancer

1 reference

12 December 2020

Prostate cancer screening: current trends and future implications

1 reference

12 December 2020

Natural history of low-stage prostatic cancer and the impact of early detection

1 reference

12 December 2020

High 10-year survival rate in patients with early, untreated prostatic cancer

1 reference

12 December 2020

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

1 reference

12 December 2020

The treatment of localized prostate cancer: what are we doing, what do we know, and what should we be doing? The Prostate Patient Outcome Research Team

1 reference

12 December 2020

Person-years of life lost due to cancer in the United States, 1970 and 1984

1 reference

12 December 2020

Prostate-specific antigen, digital rectal examination, and transrectal ultrasound in predicting the probability of cancer

1 reference

12 December 2020

The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

12 December 2020

An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team

1 reference

12 December 2020

Deferred treatment in clinically localised prostatic carcinoma.

1 reference

12 December 2020

The case for no initial treatment of localized prostate cancer.

1 reference

12 December 2020

Natural history of localised prostatic cancer managed by conservative therapy alone

1 reference

12 December 2020

Diagnosis of prostate cancer: a personal view

1 reference

12 December 2020

The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

1 reference

12 December 2020

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

12 December 2020

Disease-specific survival following routine prostate cancer screening by digital rectal examination.

1 reference

12 December 2020

Screening for prostatic carcinoma with prostate specific antigen

1 reference

12 December 2020

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

12 December 2020

The periodic health examination. Canadian Task Force on the Periodic Health Examination

1 reference

12 December 2020

Treatment of localized prostatic cancer. Radical prostatectomy versus placebo. A 15-year follow-up.

1 reference

12 December 2020

Digital rectal examination in the early detection of prostate cancer.

1 reference

12 December 2020

The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis

1 reference

12 December 2020

Incidental carcinoma of the prostate: an analysis of the predictors of progression

1 reference

12 December 2020

Trends in cancer mortality in 15 industrialized countries, 1969-1986.

1 reference

12 December 2020

Epidemiology of prostate cancer

1 reference

12 December 2020

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

12 December 2020

Cancer statistics, 1994.

1 reference

12 December 2020

Economics of screening for carcinoma of the prostate

1 reference

12 December 2020

Serum prostate specific antigen as pre-screening test for prostate cancer

1 reference

12 December 2020

Trends in prostate cancer--United States, 1980-1988

1 reference

12 December 2020

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

1 reference

12 December 2020

The epidemiology of prostatic cancer. Geographical distribution and time-trends

1 reference

12 December 2020

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

1 reference

12 December 2020

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02599070

1 reference

PubMed ID

7525903

Dimensions Publication ID

20 September 2017

0 references

1 reference

PubMed ID

7525903